text:
Popular power tools include drills, screwdrivers, sanders, saws and heatguns, which are all used for a number of different applications such as drilling, cutting,shaping, sanding, grinding, routing, polishing, painting and heating.
Advantages of corded power tools
- Size, weight and handling – corded tools dont require heavy batteries, which means theyre often lighter and smaller than cordless ones. For this reason, most professionals take a corded counterpart with them to jobs, in case they need to get into a restricted spot where a bulkier cordless tool cant fit.
- Constant power – an advantage to corded tools is theyre linked to a continuous electricity supply, so they never run out of power.
- Torque – corded tools offer high levels of torque thanks to a constant flow ofelectricity, so there arent limitations in terms of voltage .
... Read more

subset: commoncrawl


text:
Featured News - Current News - Archived News - News Categories
Antique to Chic, located at 536 Center St., in the Village of Lewiston, celebrated a grand opening and ribbon-cutting on Friday, March 1, with the Niagara River Region Chamber of Commerce, elected officials, local business owners and friends and family.
The unique, antique co-op features everything from old to new, primitives, vintage and contemporary furniture, jewelry decor and apparel.
Antique to Chic co-op is owned and operated by Judy Munzi, Jackie Carbone, Gloria Costrino, Nadine Lucas, Lucy Weller, Wendy Haley and Toddy St. Laurent. For more information on the store, call 716-754-2277.
Pictured are the owners of Antique to Chic alongside local elected officials, friends and family and members of the Niagara River Region Chamber of Commerce.


text:
Information For Authors
- Manuscript Submission Guidelines
- Author Benefits Program
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
PREPARATION OF MANUSCRIPTS - TABLES AND ILLUSTRATIONS - PROTOCOL TABLE - FIGURE LAYOUT - CONCENTRATION RESPONSE PLOTS - BAR GRAPHS - ERROR BARS AND DEFINITION - Z' FACTOR - CHEMICAL STRUCTURES - COVER SUBMISSIONS - Animal and Human Tissue Guidelines - COMPARATIVE STUDIES - REFERENCES - PERMISSIONS - AUTHORSHIP - page proofs - REPRINTS
ASSAY and Drug Development Technologies focuses on early-stage screening techniques and tools that optimize the identification of novel leads and targets for new drug development, running the spectrum from nanotechnology through cellular imaging. Case studies are presented, and technology applications are extensive. Articles published in ASSAY emphasize methodologies and technologies to accelerate drug discovery.
Included topics are: State-of-the-art research, methods, materials, and protocols in assay design and target development; High throughput screening; High throughput chemistry; Lab automation; Data analysis and information management; Microplate standards; Screen design and advanced technology; Protein structure and function; Compound library generation; Bioinformatics and data mining; Validation strategies; Biosensors; Detection technologies; Miniaturization and nanotechnology; Protein–protein interaction as novel drug targets; Novel screening methods with high information content; Metabolically engineered cells and organisms; Imaging technologies for live cells, tissues, and small animals; and Virtual screening.
Manuscripts submitted to this Journal must not be under consideration elsewhere.
Submitting Your Manuscript
ASSAY and Drug Development Technologies welcomes format-neutral manuscripts for first-time submissions. Newly submitted manuscripts will not be un-submitted for formatting issues. However, after the initial peer review process, revised submissions must follow correct journal formatting and file guidelines, as described in the Instructions for Authors.
ORCID IDs
All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.
All manuscripts must be submitted online using the following URL:
Authors must include a letter of transmittal that includes the paper's title, corresponding author's name, address, institutional affiliation(s), a telephone and fax number, (including the country and city code if outside the U.S.), and Email address. The cover letter should indicate that the work has not previously been published, is not under consideration for publication elsewhere, that all authors have read and agree with the contents of the submission, and that all authors have contributed substantially to the work.
Keywords (Areas of Expertise)
To facilitate the peer review process, select 4-6 keywords from the drop-down list of pre-selected terms when submitting your manuscript. These keywords will assist in the selection of skilled reviewers in the field for the purposes of peer review.
English Grammar and Style Refinement: The Editors' goal is for ASSAY and Drug Development Technologies to provide a global forum that promotes discourse among drug discovery researchers worldwide. Thus submission of articles by authors from non-English speaking countries is strongly encouraged. Authors whose native language is not English are advised to use an editing service to refine the manuscript before submission to ASSAY. Peer reviewers will then be able to evaluate the scientific content and organization of a paper without becoming distracted by grammatical details. Our aim is to avoid the obscuring of excellent science by a difficult to read manuscript.
Expert editors at Mary Ann Liebert, Inc. are available to refine your manuscript for word usage, grammar, sentence construction, and formatting prior to submission for peer review. Please note that use of this editing service does not guarantee acceptance by the Journal. After editing the paper it will go through the usual full peer review process. Even if the paper is not accepted by the journal, it will have been substantially improved and may then be submitted for publication in another Journal. For further information and costs, please e-mail Georgia Prince at the publisher's office: email@example.com. Please be sure to include the name of the journal and whether or not the paper has been officially submitted to the journal. Alternatively, authors may select from one of the numerous scientific editing services that may be found through a web-based search.
All text files must be submitted in Word. Do not upload PDFs. Submissions of manuscripts must be double-spaced. Please do not embed artwork or tables within the text document. Figures should be supplied in separate, individual files, be labeled clearly, and should be in TIFF or EPS formats. Tables should be supplied in a separate Word document, not in PDF format. Please see the Tables and Illustrations section for further details on art submission.
Please upload individual files of all manuscript material – do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and for the peer-review process.
Please follow this sequence of sections:
• Number each page of text consecutively. Number all figures and tables.
• Title page must contain: (1) the complete title of the paper; (2) the full names (including first names), full mailing addresses, full contact information (telephone, fax, and e-mail address), and affiliations of each author; (3) a brief running title; (4) the corresponding author's complete contact information including full mailing and e-mail addresses.
• Manuscript keywords (search terms): On the title page of the manuscript, include a minimum of three (3), maximum of six (6), search terms that will aid in the discoverability of the article in indexing services and search engines. These terms may or may not be different from the terms you selected for the peer review process and areas of expertise. You will be asked to retype these search terms in the submission form when uploading your manuscript. These keywords will be included in the published article. If the search terms entered do not match the manuscript, the manuscript will serve as the default.
• Title: Please do not use "Novel" or "New" in the article title.
• Abstract: 250 words or less, without the use of subheadings. References are not permitted in the abstract.
• Abbreviations: Please include a list of all abbreviations used in the article. All acronyms and their definitions should be spelled out in a separate list on a separate page immediately after the title page.
• Introduction: Summarize the background of the technology and its significance and novelty. Results should NOT be included in the introduction.
• Materials and Methods: ASSAY is method-oriented. Sources of specific materials, including reagents, software, and instrumentation, should be specified, marked with ™ or ® if they are trademarked or registered. These marks need only be cited at the product's first mention in the abstract, and then once again in text. Use only acronyms in text. When using specific brand names of drugs or devices, please include the manufacturer's name and location (including city and state) in parentheses.
• Results.
• Discussion: The results and discussion sections of short articles may be combined for more effective presentation.
• Acknowledgments.
• AUTHOR DISCLOSURE STATEMENT: All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript. Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultantships, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should be disclosed in the Acknowledgments section.
• References.
Letters to the Editor(s): Letters to the Editor(s) are welcomed, but with a 500 word limit and no more than one (1) table OR figure, and with a maximum of four (4) references.
Use Arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences. Provide titles for all tables. Define all acronyms in table footnotes. All other types of table footnotes should be designated using superscript letters, not symbols.
A legend should be supplied for each figure, and all legends numbered consecutively and provided (double spaced) on a separate page at the end of the main text file. All symbol definitions should be in the figure legend, not as a key within the figure. If possible, please use Arial font for figure text. One-column graphs should not exceed 3¼ inches. If a graph must be larger so small data is clearly visible, the graph should not exceed 6½ inches. Anything larger will need to be reduced and data could become illegible. The point size of axis labeling or text within figures should not exceed 12 points.
Figures should be numbered in the order cited in the text. Images should not show the name of a manufacturer or reveal patients' name(s). Please keep in mind that the figures will be reduced, so please do not submit large figures/graphs that contain small type, as the text within the figure will not be readable after reduction.
Color publication of figures is encouraged, but the cost for color printing must be subsidized by the author(s). Color costs apply to all manuscripts, including those invited, unless the contributor has made prior arrangements with the Publisher. Please consider these costs when preparing your manuscript for submission. For further details, contact the Publisher.
Please follow these instructions carefully when preparing figure files for uploading:
• Do NOT include any illustrations as part of your text file.
• Line illustrations must be submitted at 600 DPI.
• Halftones and color photos should be submitted at a minimum of 300 DPI.
• Power Point files cannot be uploaded on to Manuscript Central.
• Save art as either TIFF or EPS files. JPEG files are for screen representation-quality only and will print very poorly during the printing process. To ensure proper print quality, please submit only TIFF or EPS files.
• Color art must be saved as CYMK, not RGB. (NB: If RGB files are submitted, the files will be converted to CYMK and some color variation will occur.)
• When naming your figure files, please label them with the author's last name, followed by a period (.), and then list the figure number. Ex: Smith.Fig1.tif. Label figures and tables inside the files in addition to naming the file with the figure or table number. (ie: When figures or table files are opened, the figure or table number should appear inside the file.)
NOTE: Supplemental Information will not be copyedited or typeset; they will be posted online-only as they were supplied.
Protocol Table. Authors should include a Protocol Table having the general format as shown below to supplement the Methods section. This format will allow the optimized HTS or other assay protocols with specific comments for each step to be presented in a straightforward manner, and allow ADT to establish a consistent protocol format.
Figure layout. Figures should be on a white background, and must avoid excessive boxing, unnecessary color, a title on the figure itself, spurious decorative effects (such as three-dimensional 'skyscraper' histograms). Do not use a gray or dark background for histograms, and if possible prepare them in a professional graphing program such as Prism, Origin, etc. that matches the presentation format of, for example, dose-response plots.
Concentration response plots. Concentration or dose-response curves should be plotted using a logarithmic x-axis scale for effector (e.g., compound or ligand) concentration and a linear y-axis scale for the effect being measured (e.g., readout from plate reader, percent activity relative to control). In the case of replicate determinations, each point should represent the mean, and error bars should be used to show the SD or SEM. Points may be joined by a line or superimposed on a curve fit obtained by non-linear regression. The figure legend should report the number of replicates, the error calculation used (e.g., SD or SEM), and the type of curve fit.
This journal's conventional concentration response curve nomenclature is "Log [cpd], M". Plots may contain symbol legend within the plot itself, however this information must be also contained within the figure legend (see example below). In general, please differentiate multiple curves on a plot by the type of data point symbol. Avoid use of color if possible.
Examples below show acceptable figure layouts for the figure legend below.
Figure 1. Dose-response of active and inactive analogs of two compound series. The inhibition of esterase activity was determined for two representative compounds from the benzthiazol and quinazoline series. The IC50 of the active benzthiazol cpd 123 () was 420 ± 18 nM and the inactive stereo isomer, cpd 124 ( ), had no effect at the highest tested concentration of 6 uM. The IC50 of the active quinazoline cpd 225 () was 677± 30 nM, and the inactive ester, cpd 226 ( ∇ ), had no effect at the highest tested concentration of 6 uM. The data presented are means +/- SEM of triplicate wells (n=3).
Bar graphs. Please standardize all figures using a professional graphing software package (e.g. Prism Graphpad). Please do not use Excel for graphing if possible. For bar graphs, use the following patterns, solid, open, and hashed with three or less different conditions (see below); for an additional fourth bar reverse hash lines. Use the finest line settings (e.g. ½ point) when option is available. Avoid use of color in bar graphs.
Error bars and definition. All Figures displaying error bars (e.g., bar graphs, dose-response curves) must include in the figure legend a sentence describing how the error was determined, for example "The data presented are means +/- SEM of triplicate wells (n=3)", or "Error bars represent standard error of n=4 values", etc.
Error measurements must also accompany all reported dissociation/association constants, kinetic parameters (e.g. Km, Vmax) and IC50, e.g. IC50 = 8 ±1 uM.
Z' factor. All reported Z-factors must include within the paper specifically what 'signal' and 'background' or 'inhibited' conditions were used to obtain the data used to calculate this value. In addition, and importantly, how many wells were used to calculate the Z'? For a 96-well plate ideally half the wells (n=48) would be used as 'background' or 'inhibited' and the other half (n=48) as the 'stimulated' or 'max signal'. A typical experiment in the standard 96-well format should be shown. Example is below.
Chemical Structures.Structures should be produced with the use of a drawing program such as ChemDraw. Authors using the current versions of ChemDraw will find the necessary parameters incorporated into this program ("ACS Document 1996").
Cover Submissions. Outstanding color artwork is encouraged for possible use on the cover. The ADT cover is composed of three elements: (1) a background that fills the cover space, (2) a foreground image, and (3) the chemical structure that occupies the top right corner of the cover. Please provide a few sentences describing the assay or technology and a single sentence for each element, see example below for guidance. DO NOT REPEAT ENTIRE FIGURE LEGEND FROM ARTICLE. Authors are encouraged to submit choices of images and/or figures that would make for an interesting cover. Once the editors select the cover art, our graphic artist creates the cover. See the Cover Art Gallery for examples of previous covers.
Example Caption: LacZ expression in transgenic animals is typically assessed in vitro in tissue slices using X-gal, which is cleaved by the LacZ gene product to yield an insoluble blue cleavage product. Zhang and colleagues have developed a method for in vivo assessment LacZ expression in transgenic animals using DDAOG, which is cleaved by the LacZ gene product to yield a cleavage product with far-red fluorescence. The fluorescent product is detected using an in vivo optical imaging system. Foreground: schematic of in vivo optical imaging system (illustrator: Daniela Bednarova). Background: GPR56KO/LacZ mouse kidney medulla stained with X-gal.Upper right chemical structure: DDAOG (7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one)-b-D-galactopyranoside).
Animal and Human Tissue Guidelines
Please include within Materials and Methods your institute's compliance statements for animal experimentation and handling of human tissue. Examples:
Use of Animals. Animal experimentation complied with local and national requirements, including the UK Coordinating Committee on Cancer Research guidelines for the welfare of animals in experimental neoplasia.37
37. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Ramond R, Stables J, Stephens T: United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia [second edition]. Br J Cancer 1998;77:1–10.
Handling of human tissue. Handling of human DRG tissue was carried out according to legal provisions and rules of the medical faculty of the Innsbruck Medical University.
Authors preparing manuscripts containing comparisons of assay technologies are advised that the following points will be considered during peer-review:
• A Z-factor analysis along with the formula used to calculate the Z-factor must be included, especially if formats are fundamentally different, e.g., a ratiometric vs. a single readout assay. The authors should describe the plate format, number of wells, and plates used to obtain this statistic.
• Discrepancies in the ability to reproduce an activity of published controls must be carefully explained. Particular attention should be paid to experimental parameters and reagent properties that differ from those previously reported (e.g., enzyme specific activity, protein or compound purity).
• Product comparisons may be supported by reference to data from peer-reviewed publications. In the absence of prior peer reviewed publication, data to support (or critique) a specific product should be presented in the paper so that it will be subjected to peer review upon submission to Assay and Drug Development Technologies. Selective use of literature to support an advantage over an existing technology is inappropriate, as is selective omission of literature references to create the appearance of a competitive advantage. In general, existing literature relevant to the reported assay technology should be cited comprehensively, and negative and positive aspects should be discussed in a scientific and unbiased manner.
• Vendor manuals available online may be referenced when a method is based on a commercial kit or performed ''according to the manufacturer's instructions.'' Reviewers, however, may require details to be included in the manuscript. Data in manuals, application notes, and posters that have not been subjected to peer review may not be used to compare one product with another or to support a central argument in a paper.
• The use of promotional or marketing-like statements is not permitted. Examples of marketing terminology: "XYZ Biosciences has recently launched the first commercially available version...." "For higher throughput a plate based version, Speedy Workstation, is available. With this device screening of large compound libraries will be possible without loss of data quality." In addition please remove all terms of novelty from the title and text (e.g., novel, innovative, unique).
All references must be cited in the text using a superscript Arabic number. Arrange the reference list in numeric order as cited in the text. When there are more than six authors, list the first three followed by "et al." Abbreviate journal names according to Serial Sources for the BIOSIS Data Base (BioSciences Information Service, 1992). References should be presented in the following style: Journal citation: Ferrer M, Hamilton A, Inglese J: A PDZ domain-based detection system for enzyme assays. Analyt Biochem 2001;301:207–216. Book citation: Kahn M: High Throughput Screening for Novel Anti-Inflammatories. Birkhauser, Basel, Switzerland, 2000. Chapter in edited book: Banks M: Automation and Technology for HTS in Drug Development. In: Approaches to High Throughput Toxicity Screening (Atterwill CK, Purcell W, Goldfarb P, eds.), pp. 9–30. Taylor & Francis, London, United Kingdom, 1999. Web sites: Name of web page. Web address. (Last accessed on [date]). Example: DOE Human Genome Program Research. Available at: www.ornl.gov/sci/techresources/Human_Genome/research/research/shtml . Last accessed August 31, 2005.
When data from an unpublished source are given, supply the researcher's name and institution, and the year in which the research was conducted. If the work is in press, give the journal in which it is to be published.
This journal is included in EndNote. You may download the EndNote style file here. Please note, however, that the Publisher of this journal does not provide technical support for EndNote. For assistance with the program, contact EndNote directly (http://www.endnote.com/).
• The author must obtain written permission from the publisher of the journal or book concerned for the reproduction of figures, tables, etc., from copyrighted materials.
• The publication from which the figure or table is reprinted must be listed as a complete reference in the reference list.
• An appropriate credit line should be included in the figure legend or table footnote, and full publication information should be included in the reference list.
Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publications should be described in the form of a footnote to the title. Authors with papers under consideration elsewhere having significant overlap to those submitted to ASSAY and Drug Development Technologies should provide copies of such manuscripts to the editor. The editors maintain the option to reverse an acceptance decision should an apparent issue with publishing policies or scientific content arise. Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc. By submitting a manuscript to the Journal, the author(s) agree(s) to each of the above conditions. In addition, the author(s) explicitly assign(s) any copyrighted ownership he/she (they) may have in such manuscript to the Journal.
It is critical to ensure the accuracy of ALL authors' email addresses when uploading submissions to Manuscript Central to ensure the proper delivery of all email communications.
The corresponding author is responsible for communicating with coauthors to make sure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright.
It is the submitting author's responsibility to ensure the accuracy and inclusion of all contributing authors' names and affiliations upon submission. Once a paper is accepted for publication, changes in authorship while the paper is in production – including page proofs – are NOT permitted. Changes in authorship after publication are strictly prohibited.
It is the Journal's policy that a manuscript has only ONE corresponding author listed on a paper. This designation should be determined at the time of submission. Additions to corresponding authors are not permitted after acceptance, in page proofs, or after publication.
Page proofs will be sent to the (one) corresponding author as designated when the manuscript was uploaded to Manuscript Central. It is the corresponding author's responsibility to share the page proofs with co-authors and to coordinate all authors' corrections into one proof. The Publisher will not accept corrections from multiple authors.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
ASSAY is owned and published by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, New Rochelle, NY10801. Telephone: 914-740-2100; Fax: 914-740-2101; E-mail: firstname.lastname@example.com; Website: www.liebertpub.com
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email firstname.lastname@example.com.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: "Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]". Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email firstname.lastname@example.com or visit Liebert Open Access for more information.


text:
So let me ask you: Is that a good thing or a bad thing?
The answer may hinge on many factors, so I've pulled together a list of panel pros and cons for you to consider when you're invited to join a panel discussion as a speaker. Please do add your own pros and cons in the comments!
- Panels are a great learning experience for speakers. Serving as a panelist is one of 4 speaker stepping-stones you can use to work your way up to bigger speaking assignments. Panels are great practice to move you toward a solo speaking gig. And if you need to renew your speaking skills after having avoided speaking for a while, panels are a great way to get back in the game.
- If you're moderating the panel, you learn yet another key skill set, one that's prized by organizers. But keep in mind that moderators generally speak less--except when subbing for a last-minute no-show speaker.
- Panels offer a focused way to show your expertise. Most of the time, you'll be asked to join a panel because of your experience and expertise. You don't need to be "the expert," just an expert with a unique perspective.
- Panels help you practice extemporaneous speaking, but in a focused environment. Most panelists use just a few notes rather than a prepared text, and the panelists invite questions from the audience at some point. You'll hone the skills involved in on-your-feet responding to questions, which you'll use again and again.
- You may need to reach this audience, on this topic. You don't want your stint on a panel to be a sales pitch, but if the audience, the prestige of the meeting, or the topic are critical to you, saying yes may be the right move. Always ask "What's in it for me?" when evaluating a speaking gig, to be sure you know your motivation.
- If you've never been a panelist, there's no way to fix that except to say "yes" to an invitation.
- Audiences have strong feelings about bad panels, mostly from sitting through some awful ones. It pays to do some research: What were the reviews for last year's or more recent panels at this meeting? Ask the organizer.
- The organizers may need you more than you need this gig. Is your reputation or your marquee position lending credibility to this panel in a way you might later regret? Make sure there's a good match for you with the organizations hosting your panels.
- Being on the panel may put you in an awkward position. You may not be ready to speak publicly on a hot topic, or there may be an assumption that you'll address something about which you just don't want to speak. Perhaps the audience will assume you're endorsing the organization or a project or issue to which panelists will be asked to react---so be sure you are comfortable with the appearance that you're on board, or decline those opportunities where it appears your comments might become endorsements you didn't intend to make. What's the role they want you to play? Are you comfortable with that? Asking "what's in it for them?" also is a good idea when considering whether to get on a panel.
- The panel may be poorly organized, with too many speakers, an ever-changing agenda, too little time for each speaker, or some other logistical issue that will make the opportunity a chore rather than an advantage. There are 7 good reasons to turn down a speaking gig, so keep the list in mind when evaluating a panel invitation.
- You may be sandwiched between over-talkers. That might mean speakers who don't abide by their time limits, or speakers who talk over you while you're talking. Make sure you've discussed ground rules with the organizer and moderator, and if you can, check out the reputations of your fellow panelists before you agree to join them. It's tough to suss this out ahead of time, but ask around--you may find out more than you expect about your fellow panelists.
- You and the organizer don't agree on the panel's main purpose. If this is the case, or if you feel you're being told precisely what to say on your topic, rather than getting some leeway, it's best to decline right away.


text:
U.S. Judge Rules Apple Colluded on E-Books
Decision Threatens to Limit Tech Company's Options in Future Content Negotiations
Apple Inc. AAPL 1.51% colluded with five major U.S. publishers to drive up the prices of e-books, a federal judge ruled Wednesday in a stern rebuke that threatens to limit the technology company's options when negotiating future content deals.
The ruling—which follows Apple's high-stakes gamble to go to trial even though the publishers settled similar charges—exposes the tech company to as-yet undetermined damages and opens the door for the Justice Department to take a closer look at its other business lines. In settling, the publishers denied wrongdoing.
At issue are the steps Apple took to gain a foothold in e-books for its iTunes online store. The iTunes store is a strategically vital area that accounts for about 10% of Apple's revenue and faces fierce competition from rivals—in particular Amazon.com Inc. AMZN 0.12%
E-Books Ruling Against Apple
See the full ruling document with key sections highlighted.
Related Articles
- A Guide to Apple's Deal Making
- How Ruling Could Affect iTunes Group
- For Apple, a Tough Legal Road Grows Longer
- Digits: E-Books Judge Questions Credibility of Apple's Eddy Cue
- Law Blog: What Happens Next?
- Law Blog: Highlights From the Ruling
- Will E-Book Prices Fall? No
- Why Apple Didn't Settle Suit
- Apple's Civil Antitrust Trial: The Highlights (6/20/2013)
- Why Apple Is Still Battling Over E-Books (6/28/2013)
- Apple Starts E-Book Trial at a Disadvantage (6/2/2013)
Justice Department prosecutors argued that Apple used publishers' dissatisfaction with Amazon's aggressive e-book discounting to shoehorn itself into the digital-book market when it launched the iPad in 2010. Apple's proposal: Let publishers set prices themselves. That led to Amazon losing the ability to price most e-book best sellers at $9.99, causing prices to rise.
In her ruling, U.S. District Judge Denise Cote in Manhattan said the evidence was clear that Apple, despite its claims that it negotiated fiercely and separately with each publisher, was at the center of the conspiracy.
"Understanding that no one publisher could risk acting alone in an attempt to take pricing power away from Amazon, Apple created a mechanism and environment that enabled them to act together in a matter of weeks to eliminate all retail price competition for their e-books," she wrote in a 160-page decision.
Apple said it did nothing wrong and said it plans to appeal. "Apple did not conspire to fix e-book pricing and we will continue to fight against these false accusations," an Apple spokesman said. "When we introduced the iBookstore in 2010, we gave customers more choice, injecting much needed innovation and competition into the market, breaking Amazon's monopolistic grip on the publishing industry."
Consumers won't see changes in e-book prices as a result of the ruling. Prices of many best-selling titles had already come down after the major publishers settled.
Apple's decision to fight the Justice Department underscores the stakes in the case. The company makes most of its money selling iPhones and iPads. But its iTunes service has become a central part of its offering with huge volumes of electronic content enticing people to buy and upgrade Apple products.
The company has been an aggressive bargainer, successfully opening up new markets for electronic content, most notably with music. But the ruling raises questions about the leverage Apple may have when negotiating future content deals.
The Justice Department itself isn't seeking monetary damages but has instead asked the court to adopt a variety of measures to ensure Apple doesn't engage in similar conduct in the future. This includes not entering "most-favored nation" clauses requiring publishers to match competitors' prices in Apple's digital bookstore, and possibly ending the company's practice of charging a 30% commission on books sold through third-party apps in its App Store.
The judge, who will hold a hearing on those requests, could choose to heavily regulate Apple, legal experts say, potentially slowing deal-making with content partners for new products, such as its long-awaited television. "Under antitrust law, you can not only prevent the unlawful conduct, but also prevent other conduct that can lead to a similar result," said David Balto, former policy director at the Federal Trade Commission.
Because Apple was found liable for violating U.S. antitrust laws, a separate trial on damages will take place in a lawsuit against the company brought by 33 state attorneys general, who are seeking to recover money on behalf of consumers who paid higher prices for e-books. Apple also faces a private class-action suit alleging price-fixing. The private plaintiffs could recover damages from Apple, provided their legal claims are distinct from the states'.
In the ruling, the judge pointed to comments by Steve Jobs, Apple's co-founder and CEO who died in 2011, as "compelling evidence of Apple's participation in the conspiracy."
In emails introduced as evidence, Mr. Jobs seemed to gloat after published reports in January 2010 that Macmillan and Amazon were separately clashing over pricing following the Apple deal. "Wow, we have really lit a fuse on a powder keg," Mr. Jobs wrote in an email from Jan. 30, 2010.
In a group email at Apple the next day, Mr. Jobs said: "We have definitely helped stir things up in the publishing world."
Judge Cote said she wasn't persuaded by testimony from Eddy Cue, an Apple senior vice president who led negotiations with publishers, who argued that his company's only motivation was to get the best deal from publishers.
The judge said she believed Mr. Cue was driven in his negotiations by a desire to please Mr. Jobs. "Cue knew that Jobs was seriously ill and that this would be one of his last opportunities to bring to life one of Jobs's visions and to demonstrate his devotion to the man who had given him the opportunity to help transform American culture," Judge Cote wrote.
Mr. Cue didn't respond to a request for comment Wednesday.
When it entered the e-book market in 2010, Apple agreed to shift to a so-called agency model in which publishers, rather than retailers, set the price of e-books. As part of its deals with the publishers, Apple received a 30% commission on each book sold and the publishers had to match the price of Amazon or other competitors if the competitor's price was lower.
Amazon declined to comment.
At the time, Amazon was the dominant player in the market, accounting for between 80% and 90% of all e-book sales. However, the major publishers were concerned that Amazon was selling books at a loss in order to gobble up market share and had threatened to begin withholding some of their most popular books from the online seller.
The odds of reversing the decision and avoiding damages are long, some legal experts said. The outcome may be similar to the Justice Department's lawsuit against Microsoft Corp. The U.S. Court of Appeals for the District of Columbia was constrained by the judge's heavily fact-based opinion and in 2001 upheld many of his inferences, said Keith Hylton, a professor at Boston University's School of Law.
The Apple case could resonate beyond e-books, with broader implications for providers of everything from music to movies. "If you're a tech company and you are looking to aggregate content, you have to be exceptionally conscious about how you talk to your suppliers," said Ankur Kapoor, an antitrust lawyer at Constantine Cannon LLP. "U.S. v. Apple has put these communications under a very fine microscope."
Apple has recently shown signs of more flexibility in its negotiations. Many of the terms of Apple's royalty agreements for its radio service, for example, were more generous to the music companies than what rivals, such as Pandora Media Inc., pay.
Apple's reputation appears unharmed, according to Mark Patterson, a professor at Fordham Law School who specializes in antitrust matters and agreed with Judge Cote's ruling. "The consumer response is a big yawn," he said.
Its shares were little changed on the news, dropping less than 1%, to $420.73 on Wednesday. The stock, however, has fallen about 30% in the past year amid concerns that its growth is slowing.
—Jeffrey A. Trachtenberg
and Jacob Gershman contributed to this article.
Write to Chad Bray at email@example.com, Joe Palazzolo at email@example.com and Ian Sherr at firstname.lastname@example.com
Copyright ©2020 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8


text:
We use cookies to improve our website, provide more personalised services to you and analyse our traffic.
To find out more information about our use of cookies please read our Cookie Policy
The Innovation Partnership Programme can help you to take your business to the next level. Enterprise Ireland can help your company to access the latest skills and expertise from research institutes throughout Ireland.
The Innovation Partnership Programme can provide up to 80% of the cost of research work towards the development of new and improved products, processes or services, or generate new knowledge and know-how.
In an independent survey of companies that participated in the Innovation Partnership Programme:
<!-- Youtube Video -->
The company must be a registered client of one of the following state development agencies: Enterprise Ireland, IDA Ireland, Local Enterprise Office, Údarás na Gaeltachta.
The company must have the full support of their assigned Development Adviser/Agency Contact to participate in the programme. This support must be confirmed before any application forms are submitted. Clusters of companies and/or research institutes are welcome to apply to the programme.
Our Innovation Partnership brochure provides the essential details on funding, eligibility and key dates.
Whatever sector that your company is in, from Big Data to Medical Devices and beyond, you can find research partners through the Research Map of Ireland.
Below is the schedule for FULL Innovation Partnership Proposals for 2020.
For more information on the Innovation Partnership Programme, please email firstname.lastname@example.com
Programme Manager - Innovation Partnerships
Enterprise Ireland
Lawrence Lee
+353 1 727 2232
Company Liaison - Innovation Partnerships
Michael Treacy
+353 1 727 2740
Programme Executive - Innovation Partnerships
Eileen McGoldrick
+353 1 727 2733
European Regional Development Fund (ERDF)


text:
I was inspired to create my own painted background for this layout from the artwork, rather than use any patterned paper.
Hi! I'm Michelle! I have been scrapbooking with passion about for 15 years! I love bringing precious memories to life with my own creative style. I have been on a few Design Teams over the years including Scrapbook Supplies Online, Artastic, Tattered Inspirations and Black With 2. I've also had my work published in Scrapbooking Memories and received an Honourable Mention in this year's Masters competition. I am a full-time primary school teacher by day and I do love my job because it is a rich and rewarding experience!
Here are some more examples of my work ...
Thank you so much for guesting with us on ARTastic this month Michelle. It has been really lovely having you join us.
Remember ....
You still have time until the end of the month to upload your own take on this challenge. All details are on the blog sidebar. We'd love to see what you can do with our inspiration this month.


text:
Recently I got into a conversation about Euro2012 with someone who is, well let's say, from the other end of the political spectrum. It turned out we both had gripes about how our respective political camps were interpreting Euro2012.
Her main complaint was that some elements of the conservative-right in Poland were criticising Poles for only bearing the flag and expressing their patriotism during a football tournament and not during national days of patriotic celebration. She pointed out that this was a narrow-minded approach and that they should instead welcome this mass display of national pride.
On the other hand, I expressed my dismay that many on the left were only pointing out the negatives of the tournament. They portray Euro2012 as a celebration of nationalism, commercialism and misogogony, that wastes billions of złoty that could have been spent on more worthwhile projects (this latter point I have already made myself) and ignores the huge social and economic problems building in Poland.
I will leave aside the debates occurring on the conservative right (I have no real knowledge or concern for these) and consider what should the attitude of the left and other progressive forces be to Euro2012. Debates about whether the tournament should have been organised or not are now a thing of the past, the point presently is whether anything positive can be taken from the experience.
As the tournament enters its final week we can first of all say that Euro2012 has been a success. This is not just the opinion of the media or elite but a feeling that runs through the vast majority of society with 88% of Poles positively assessing the decision to jointly organise the tournament with Ukraine.
I believe that there are two main outcomes of Euro2012 that the left should welcome and seek to build on.
Anti-Racism and Multi-Culturalism
Anti-Racism and Multi-Culturalism
Euro2012 opened shortly after the broadcasting of a documentary by the BBC that reported the existence of racism in stadiums in Ukraine and Poland. It was accompanied by leading black former footballers claiming that they and their families would not travel to Poland or Ukraine as they feared racist attack and abuse.
I have mixed feelings about this programme. On the one hand it was good that the media displayed how racism does exist in some football stadiums in Poland and Ukraine and opened up a debate on this matter (a topic that has largely been ignored by the domestic media.) However, the programme was so one-sided that it gave the impression that the stadiums would be full of rabid racists hurling abuse at black players and attacking fans of different nationalities and races. This could not be further from the reality of Euro2012.
As I left Warsaw's fanzone after watching a game last week, I overheard an exchange between two Polish fans. 'The problem with the BBC documentary is that they didn't show things like this', was the gist of their conversation. It's a sentiment that has often been expressed and one that reflects a frustration amongst the 99% of Poles who have embraced the spirit of Euro2012 as one of openness and diversity.
In the 15 years that I have lived in this city I have never seen it quite like this. The streets are full of fans and tourists, with people of different nationalities and races intermingling and celebrating this festival of football.
There is of course a problem of racism and xenophobia in Poland, as there is in Ukraine. It is true that racism can sometimes be expressed openly, including on the terraces of football stadiums, in a way that is no longer acceptable in countries like Britain. However, Euro2012 has shown that these are the actions of a minority (often connected to the far-right) and can be marginalised as they are seen to be unacceptable by the majority.
This is not helped by those in Western Europe portraying countries like Poland as being hotbeds of racism. This is particularly hard to swallow in countries that have never had histories of colonial conquest, never participated in the slave trade and have not built their economies on the exploitation of immigrant labour.
It is also difficult to accept the tone of superiority of those from a country that has its own fresh experiences of racism in football. This does not end with the convictions and allegations of racism on the pitch made against leading Premier League and English national team players last season. It extends to the racist and Islamophobic English Defence League, which is organised around football hooligan groups that now terrorise on the high-streets instead of in the stadiums.
The problem of the far-right also exists in countries like Poland and Ukraine. Beyond the newly developed stadiums and corporate fanzones, lie some deep pockets of poverty and social exclusion. The process of deindustrialisation and its subsequent high unemployment and social inequalities have created fertile breeding grounds for those seeking to spread their message of hate.
These countries have at times in their history been isolated from other parts of the globe and once opened up to the West have tended to experience large emigrations. These are not multi-cultural societies in the western sense and this has bred a racism built more upon ignorance than that of superiority that is common in the ex-colonial centres.
Euro2012 has gone some way to opening up Poland to other cultures and nationalities and has dismantled many stereotypes of Poland and Poles from those visiting the country. It has been almost amusing to watch the supporters from various countries falling over themselves to become friends of Poland, seeing who is able to sing loudest the Polish chant 'Polska Biało-Czerwoni'.
The State can be Effective
The second major success of Euro2012 has been the example of how the state can be an effective instrument in socio-economic life. For more than two decades the ideology has been propagated that the state is inefficient, wasteful and bureaucratic and that the private sector should replace it. This has become a self-fullfilling prophesy as successive governments have starved the state of resources.
Euro2012 has dispelled this myth and shown that the state can be a successful and efficient investor and organiser. It has been public investment organised by the state, using national and EU funds, that built the stadiums, roads, railways, train stations, fanzones and transmitted the matches on national television. Yes, we can argue about whether the money should have been spent better elsewhere, but now this has been done be we should be pointing out what successes can be gained by the state coordinating its activities around a clear project that is supported by the majority of society. Most crucially the left should be underlining that it is only by the state furthering its investment, that the Polish economy can continue to defy the recessionary pressures building once again in Europe.
An efficient well organised and active state that exists alongside and open and tolerant society? Well we can dream, but Euro2012 has taken us a small step further towards this goal and this at least should be welcomed.


text:
Inveralmond Road
Inveralmond Industrial Estate
Tel: 0800 574 574
Web: Visit Website
We would like to take this opportunity to reassure you that Flogas Britain Limited is very much working on a 'Business as usual' basis. We have robust systems in place, a great workforce and office team who are confident we can continue through this difficult period. We have also enabled our work force to work from home to protect those who are at a higher level of health risk, and to ensure an uninterrupted service to our customers.
If you wish to place an order for delivery, you can do so by calling us on 0800 574 574.
Alternatively you can place your order via your online portal https://my.flogas.co.uk/ or by visiting our online shop here.
Our sites are open for collections where required, however why not take advantage of our quick and free delivery service which can be arranged using the details above.View full times
Monday -
Tuesday -
Wednesday -
Thursday -
Friday -
Saturday Closed
Sunday Closed
Free Delivery
Actual stock may vary. To avoid disappointment, contact the stockist ahead of time to check their current stock.


text:
'Bigg Boss 7' mix of sweet, sour moments: Apoorva Agnihotri
Fights and arguments seem to have become the mainstay to survive in the 'Bigg Boss-Saath 7' house but the inmates also share some happy moments, says actor Apoorva Agnihotri, the latest to be ousted from the reality show
"There are fights in the house but people are sweet to each other too. Only the fight scenes are shown on screen. But it is actually a mix of both. I enjoyed my time in the house," Apoorva told IANS over phone from Mumbai.
Nevertheless, the actor feels 'liberated' to be out of the show.
"It was fun and an adventure. But I am happy to go back home," he said.
The 'Pardes' actor was not seen to engage in any kind of arguments and was often seen calming other contestants down.
"I was just being myself. I can't say it was tough. There was no situation which involved me directly. So it was not tough to maintain my calm," he said.
Sign up for all the latest news, top galleries and trending videos from Mid-day.comSubscribe


text:
The Correct Order to Apply Your Skincare
Peeps, I know it seems crazy that I'm so militant about following this specific skincare regimen (and I really am, YOU MUST DO THESE THINGS IN THIS ORDER), 😉 but I swear, if you treat your skin with proper TLC, you're gonna be stoked by the results in the long run ('cause we all wanna look like fine young homies when we're 92). So if you've ever wondered whether you're supposed to apply moisturizer before or after eye cream, or WTF serum is and when it's best to slather that ish on your pretty lil' mug, I'm here to help!
The Correct Order to Apply Your Skincare
- Makeup Remover – De-gunk dirt, oil, and makeup before even starting the cleansing process!
- Cleanser – Be sure to use a cleanser than suits your skin type (dry, oily, mature, etc.), and try to use products that don't contain fragrance, parabens (and other potentially toxic preservatives), or harsh detergents that can be drying and counterproductive.
- Toner – Toners help restore your skin's natural pH, and they are often mega hydrating and packed with active ingredients to treat and soothe skin.
- Zit Cream (if needed) – This part is self-explanatory.
- Serum – These quick-absorbing, nutrient-rich treatments usually come in gel form and typically cater to speciifc skin types (acne-prone, mature, dry, etc.).
- Eye Cream – I like to use a heavy duty eye cream under my eyes and around the outside corners where crow's feet typically appear (←hopefully not for a very long time!)
- Moisturizer/Anti-Aging Oils – I like to use a light moisturizer for daytime and a thick-ass, mega rich and creamy moisturizer at night. Sometimes, I'll just slather pure argan or marula oil on my face before bed… when I rock this style, I wake up with the softest, smoothest, yummiest skin ev-ah!
Optional Steps
- Exfoliator/Scrub – A couple times a week you should exfoliate your skin using a good facial scrub to slough off dead skin cells.
- Face Mask – If you're dealing with a bout of stubborn acne or if your skin in begging to be quenched with moisture, treat yourself to a a weekly mask. It'll do your skin wonders, and it's a nice spa-sy thing to do for yourself.
Do you have a favorite vegan and cruelty-free skincare product that you can't live without? Let me know in the comments below!
About Sunny (Sunny's Profile)Longtime vegan, hardcore compassionate beauty junkie, serious cake aficionado, and lover of all things floofy and sparkly! If there's something in particular you'd like me to review, drop me a line at email@example.com. You can also find me on Facebook, Instagram, Twitter, YouTube, and Google +.
Filed in: vegan skin care
Comments (8)
Trackback URL | Comments RSS Feed
Hi Sunny! Should I exfoliate before cleansing or after?
I love 100% pure Red Wine Resveratrol Eye Cream. It's the only eye cream I've ever tried that doesn't seem to irritate my skin or make my eyes sting. I actually got my boyfriend hooked on it too!
Thanks so much for this guide! I do have a question though, when adding an exfoliator or mask to the regimen what step would it be? Thanks again 🙂
Thank you for this! I always wondered which order to use all the various products for maximum effect. Do you have a specified order for glopping things on in the first place too? Does sunscreen go before primer? Is concealer supposed to be first or last (heard it both ways, confusing??)?
Hi Sunny!
Can you tell me what is your current eye cream? I'm 30 and I'm starting to have crow's feet and it's making me so depressed T_T
I've been using Queen Bee under eye cream for 2 months but I can't seem to notice any results (good or bad).
Thanks 🙂


text:
COMMERCE CITY, Colp. – The first Colorado tryout in the seven-year history of Sueño MLS, presented by Allstate, opened the floodgates for a bevy of pent-up talent at Dick's Sporting Goods Park on Saturday.
Dozens of goalkeepers and hundreds of field players had less than 60 minutes each to convince Colorado Rapids development coaches and goalkeeping legend Felix Fernandez to include them in Sunday's pool of 30 players.
Only 10 preregistered players failed to show, and the wait list of 200 grew longer during the day. For Brian Crookham, senior director of youth development for the Rapids, the flood of quality challenged his staff to look for subtle differences.
Sueño MLS: Florida's Luis Aranzazu hitches ride to tryouts, then snags "Portero All-State" honors
"At this age, they've got to have good technique," Crookham said. "They must be able to manipulate the ball. From there, you look at their decision-making, their physical makeup and their psychological makeup."
The format included 12 full-field games with 25-minute halves on two adjacent artificial-turf fields. Games started at 9 am MT and continued until the Rapids hosted the Seattle Sounders across the street seven hours later.
During the noon hour, Fernandez ran the goalkeepers through a series of tests while Rapids players Martín Rivero and Jaime Castrillón spoke to field players.
"I always had the dream," Rivero recalled. "It takes dedication, sacrifice, and working hard, but you should also make sure you are happy being on the field."
Although most of the talent pool came from Colorado, some of the 30 finalists listed below traveled from Texas, Florida, Kansas, Nebraska and New Mexico. Ages ranged from 14 to 17 and the physical stature varied accordingly, but the soccer sophistication was consistently high.
"We were very conscious of their birth dates," Crookham explained. "We compared the criteria where they should be in their development, not necessarily if an 18-year-old could bully a 14-year-old."
Sueño MLS: Even short of his best, Maryland teen Bret LaBonte earns finals trip
The high-paced games featured aggressive, assertive play without major injuries. With three defenders, four midfielders and three attackers on each team, players wore traditional numbers to reflect the position they registered to play.
The format on Sunday allows players to show versatility in different positions and other characteristics.
"As the quality of the play tightens up," Crookham explained, "we'll see who can separate themselves from the group."
Looking ahead to the final selection of five field players and one goalkeeper on Sunday, Crookham said, "That's where the pressure cooker comes in. We'll focus our efforts on sorting apples and apples. Today was a fruit salad."
GK – Livan Aguirre (Brownsville, Texas)
GK – Daniel Ontiveros-Rascon (Denver, Colorado)
GK – Juan Pacheco (Thornton, Colorado)
RB - Jonathan Amador (Lexington, Nebraska)
RB - Amon Frazier (Colorado Springs, Colorado)
CB - Erik Alejandro Alonso (Brownsville, Texas)
CB - Jorge Ramirez (Aurora, Colorado)
LB - Erik Barragan (Garden City, Kansas)
LB - Luis Salas (Wheat Ridge, Colorado)
DM - Marco Carillo (Pittsburg, Texas)
DM - Angel Perez Rodriguez (Longmont, Colorado)
DM - Brian Loaiza (Royal Palm Beach, Florida)
DM - Gilberto Galvan (Commerce City, Colorado)
RM - Jose Felix Elias (Aurora, Colorado)
RM - Gilberto Tovar (Garden City, Kansas)
RM - Luis Galvan (Commerce City, Colorado)
LM - G. Ty Lang (Denver, Colorado)
LM - Brayan Arreola (Denver, Colorado)
LM - Juan Hernandez Rodarte (Evans, Colorado)
AM - Miguel Jaime (Glendale, Colorado)
AM - David Amaro (Garden City, Kansas)
AM - Fernando Hernandez (Englewood, Colorado)
RF - Jonathan Roman (Denver, Colorado)
RF - Alvaro Omar Sandoval (Centennial, Colorado)
RF - Hector Rodriguez (Wellington, Colorado)
CF - Jose Antonio Hernandez (Dallas, Texas)
CF - Cristian Prado (Aurora, Colorado)
CF - Jason Alarcon (Santa Fe, New Mexico)
LF - Ismail Mbaruku (Denver, Colorado)
LF - Alejandro Avila (Lakewood, Colorado)


text:
Franz Ferdinand | DOMDVD2 | Released: 28/11/05
Over 4 1/2 hours of footage! The two discs will not only include live performances from around the globe but also a myriad of very special bonus features. The first disc features tracks drawn from live performances around the world including last year's legendary performances at T in The Park, Glasgow Barrowlands and the Brixton Academy in London. This first disc also includes extensive footage of the bands 5th ever gig at the Glasgow School of Art in 2003 as well as karaoke films for Matinee & Take Me Out giving viewers a chance to sing along to their favourite Franz classics! The second disc features 2 full live performances from last years shows at Brixton Academy and San Francisco. The second disc also includes 3 extra live songs taken from the bands 2004 Australian / New Zealand tour.


text:
Read about our staff's favorite pet food.
Staff Picks for Natural Pet Food
Published by Only Natural Pet
About Us Only Natural Pet, Boulder & Aspen, Colorado USA - offers natural dog and cat products of the highest quality consistent with a holistic approach to pet health. We strongly believe that our animal companions benefit from natural living in the same way that humans do. We have quickly become the leading online natural pet care company and we are committed to honest ingredients to remain at the forefront of the industry as we continuously add healthy, natural and organic products to our inventory. Our goal is to greatly improve the health, happiness, and longevity of our pets lives. All of the products offered for sale at Only Natural Pet are of the highest quality and made of natural ingredients. We do not offer products that contain substances that could be considered dangerous, carcinogenic, unhealthy, or harmful to the environment. We have a rigorous screening process for selecting products that we offer for sale, and we work closely with our Veterinary Board of Advisors in this evaluation process and in formulating our own Only Natural Pet brand products. You can feel good about buying supplies for your animal companion at our store, because we only sell natural products that we would feel good about giving to our own pets. Only Natural Pet takes our environment into account in everything that we do. Our company is 100% powered by wind energy. Our packaging aims to reduce waste, conserve valuable resources and benefit the environment. We reuse recycled boxes and packing materials, and purchase only fully biodegradable, non-toxic packing peanuts made from cornstarch. We are working to become a Zero Waste company, which means that we strive to prevent waste, and reuse, recycle and compost as much as possible. This includes paper, plastic bottles, pallet wrap plastic, food waste, and cardboard. We use 100% recycled paper, recycle used ink cartridges, and have a Charm Program to recycle hard-to-recycle products and plastic can wrap. We additionally seek out manufacturing partners who share these values. Only Natural Pet also calculates our organizations Carbon Footprint, which measures the impact human activities have on the environment in the amount of green house gases produced. This Footprint helps us to determine ways we can reduce carbon emissions. Many members of the retail store, corporate office, and warehouse bike to work, and an Eco-Pass is available to promote public transportation. Our Honest Promise Quality Standards We pride ourselves on carrying products or brands that make use of natural, organic, hemp and free-range resources, and we support fair-trade and cruelty-free practices. Everything offered by Only Natural Pet is completely safe and non-toxic. We sell our own line of products that are guaranteed to your satisfaction and work with partners and companies who have the same level of integrity and commitment to cruelty-free and environmentally-conscious products. In evaluating a new product we take great care to ensure that it is of the highest quality and upholds our standards as a company. For pet foods there are a variety of points we look for including the quality of the protein source, amount of grain by-products, and any artificial ingredients such as preservatives, colors or flavors. None of the foods we carry contain animal by-products, artificial colors, artificial flavors, fillers or chemical preservatives. Most are human grade with USDA approved meats. Many of our foods are grain-free or offer specific benefits for allergies, weight issues and other health conditions. View all posts by Only Natural Pet


text:
Juniperus species
Trees and Shrubs, Herbs, Bonsai
Soak 24 hours and surface-sow seed; optionally stratify 6 weeks, though usually not needed. Needs light and cooler temperatures to germinate. Root cuttings using the strongest rooting hormone, take cuttings throughout growing season but ideally fresh tips in the new year. Ring-bark in early spring, for quick to slow results. Used as bonsai. Likes sandy, well-drained soil, tolerates alkaline soil well, grow in sunny spot
Some species, including Juniperus communis and Juniperus horizontalis, creeping juniper, do well in drier settings; the latter especially thrives under adverse conditions. Many hardy to zone 2
Related Topics
|Copyright © 2020,
All rights reserved


text:
supernova, a massive star in the latter stages of stellar evolution that suddenly contracts and then explodes, increasing its energy output as much as a billionfold. Supernovas are the principal distributors of heavy elements throughout the universe; all elements heavier than iron are produced in supernovas. Supernovas also are the principal heat source for interstellar matter and may be a source of cosmic rays. Recent discoveries have confirmed an underlying connection between supernovas and gamma-ray bursts (GRBs). Both are associated with the deaths of massive stars and they often happen nearly simultaneously. There is no generally agreed upon model for how a massive star explodes. However, the association with gamma rays has renewed interest in the role played by stellar rotation and magnetic fields.
Sections in this article:
The Columbia Electronic Encyclopedia, 6th ed. Copyright © 2012, Columbia University Press. All rights reserved.
See more Encyclopedia articles on: Astronomy: General


text:
- Equipe pro
- Communauté MHR
- Chronique
Le 11 mars 2013
The H Cup paid a visit to Montpellier on Friday night, photographed on the pitch pre match with a selection of the Pro and administration staff; it was then transferred upstairs for the sponsors and partners to have their chance. You could read the thoughts on every bodies faces, when was Montpellier going to get their name on this sacred trophy sooner than later hopefully. The club has invested heavily in overseas and home produced Internationals hoping that next season could be Montpellier's year, but after the game on Friday evening against Racing Metro 92 a certain amount of doubt could be coming to the surface. Toulon did exactly the same a couple of seasons ago a star studded team but at the end of the season no H Cup qualification, this surely cannot happen to our beloved, Montpellier are not there yet, but took a massive step backwards going down to Racing by 15-17, the defensive bonus point was obtained but that is not enough, depending on Saturdays results Montpellier could find themselves in the very unsavoury 7th place and struggling to qualify for next seasons H Cup. There are just 5 games left before the ¼ final play-offs, 2 at home, Toulouse and Perpignan, and 3 away, Grenoble, Mont de Marsan and Bayonne, somewhere along that ending journey there needs to be no more loses at home and 2 out of 3 wins away, not an easy task. Racing with 7 wins on the trot came looking for an 8th and they brought a big team with a huge pack of forwards, and their backs were not too shabby either, they were not coming for the ride. The evening had a look of Argentinean Tango about it, with 9 of the countries players present plus of course coaches Ledesma and Quesada. Montpellier on the other hand, decimated by injuries plus the International absenteeism for the 6 Nations A and B fielded a team with a look that has not been seen so far this season.
The first half was all Racing and they produced two fine attacking tries which left the Montpellier defence at sixes and sevens, Ollie Barclay was having an off day with the boot which did help the home side somewhat, but at the break Racing were ahead 3-17, Montpellier had already lost Thibault Privat and Jimmy Nagusa to injury, when it rains it pours, the home side could be looking at building an extension to their infirmary if the situation does not get any better. Words were said at half time and Montpellier did come out with a different face on. Benoit Paillaugue playing at 10 slotted 5 penalties missing only one, and that one was from long range, but with much more aggressiveness Montpellier tried their very best to get on level terms with Racing but a well organised defence kept the home side out throughout the last 40 mins. The Ref Mon. Raynal had to be stretchered off with a double fracture of his left leg after a very awkward fall; the assistant ref took the whistle. You know when things are not going your way, there was confusion when Galletier came off the bench, firstly it was Alex Bias who was replaced then the coach decided to bring off Alex Tulou, seconds later Bias went down with a massive cramp and also left the playing field, Charles Geli the replacement hooker had to join the back row just another piece of bad luck for Montpellier. How ever hard Montpellier tried it just would not happen and they finally had to satisfy themselves with one very small point, after spending the last 10 mins. camped on the Racing try line.
The next match is away to Grenoble on the 23rd of March, no less than a win, or complications may arise. The team is off on a rebuilding and confidence preparation in the alpine mountains of Tignes, somehow I do not think that snowballing or building snowmen will be on Fabien Galthie's agenda, running up and down mountains at speed could be his plat du jour !!!!!
Steve Whittell.
A voir aussi
Equipe pro
Equipe pro


text:
New safety rules will be enforced starting Feb. 28 for those popular play yards, which many parents use for their small children. Play yards used to be called play pens.
The Consumer Product Safety Commission says the new rules were written in response to the death of a Chicago area boy. He suffocated when the play yard he was napping in collapsed.
The Consumer Product Safety Commission says play yards that meet the new safety standard must have:
- Side rails that do not form a sharp V when the product is folded. This prevents a child from strangling in the side rail.
- Stronger corner brackets to prevent sharp-edged cracks and to prevent a side-rail collapse.
- Sturdier mattress attachments to the play yard floor to prevent children from getting trapped or hurt.
In addition to the play yard safety standard, CPSC has issued mandatory safety standards for cribs, children's bed rails, baby bath seats, baby walkers, infant swings and toddler beds.
CPSC staff is currently working on safety standards for bedside sleepers, hand-held infant carriers, bassinets, and bassinet attachments to play yards and will propose rules this year for strollers, soft infant carriers and infant slings.
If you use a play yard, keep it bare when you put your baby in it. Each year, CPSC receives reports of infant suffocation deaths. Some key causes of these deaths are the placement of pillows and thick quilts in a baby's sleeping space and/or overcrowding in the space.
Here's a link to the Consumer Product Safety Commission: www.cpsc.gov


text:
Somewhere in France
August. 16th 1918
Dearest sister Madaline:
Just a few moments before drill call so I thought I would write you now instead of tonight. We received our pay yesterday for June for which I received 107 francs. Uncle Sam still owes us for the month of July but why worry about July's pay when we are financially fixed. This is our second payment so far since we arrived in france so you see pay is very slow in reaching us although its always sure to appear. Of course 107 francs sounds as big as one hundred dollars but between the French people and their enormous prices I don't think it lasts very long. I bought a Waltham worked watch (wrist) for twenty francs for which we would have to pay $16 back home although it only cost my about five dollars. We are at our rest camp and am living the life of really. Guess I will close with plenty of love and kisses to you all, I am.
Your Brother.
Corp. J. Maus
105 US Inf. Co A
American E.F.
PS: Did you or Anna receive my photos yet?
After reading the star I noticed that Principal Sweeney of Public School 6 wishes to have all boys names who are doing service over hear. Would you ask John to do that for me immediately.
© Copyright 2011 by Lanny & Patti Brown, All Rights Reserved. No reproduction without permission.


text:
Loretta Long (b. October 4, 1938)[1] is an actress, singer, and educator who has played Susan on Sesame Street since the show's debut in 1969. In the earliest seasons, she also lent her voice to Muppet characters, including Roosevelt Franklin's Mother, Suzetta Something, one of the Anything Muppet backup singers in "Mah Na Mah Na", and the mother in "Five People in My Family", amongst others. In 2016, Long published her autobiography, My Best Friends Call Me Susan.
Born in Paw Paw, Michigan as Loretta Mae Moore, Long's father was a welder and her mother worked for Mary Kay Cosmetics. Her ambitious parents enabled her to attend Western Michigan University, where she earned an undergraduate degree in education and took theater classes on the side. After graduation, she moved to New York City, where she continued to take acting classes while teaching English as a substitute in the city and Yonkers.[2]
Long began her television career in 1967 on the variety series Soul!, which was produced at the New York public television station WNET. The series combined musical variety with frank talk on political and social issues affecting African-Americans, and played host to such performers as Stevie Wonder and Patti LaBelle.
In 1969, Long found Soul! set decorator Charles Rosen preparing a model of a street, and learned it was for a planned educational children's show. He encouraged Long to audition. She recalled the experience:
"So, I never could get Charlie Rosen to admit it, but he left out an essential piece of information. They wanted a Joan Baez-type folk guitar player... I looked more like Angela Davis than I looked like Joan Baez... I had big hair, short skirt, and show tunes. Well, I show up, and they said, 'Where's your guitar?' I said, "What guitar?' They said, 'Everybody here plays the guitar, so stand over there.'
Now, see, I always tell kids these are defining moments in your life. See, I could have got huffy and puffy and went back up to the Bronx, but I came all the way downtown in a cab to keep my Afro together, so I stood over there. So, I waited and waited and waited, and they were getting ready to leave. And I said, 'Uh, could I give my music to the piano player so I can sing for you?' They said, 'We didn't hire a piano player. Everybody here plays the guitar.' And I said, 'What?! But I came to sing for you.' So, very unenthusiastic, they said, 'OK, so sing.'
So my audition was I laid my music down... I started patting my foot, clapping my hands... [singing] 'I'm a little teapot, short and stout, here is my handle here is my spout.' And I looked right at the camera, and I said, 'Everybody sing.' And the little kids in the daycare, when they played the tape -- I said, 'Everybody sing, they all stood up and started to sing. So that -- I have some 4-year-olds to thank for a career.[3]"
While playing Susan on Sesame Street, Long also commuted to the University of Massachussetts on her days off, pursuing a doctorate in Urban Education. She received the Ph.D. in 1973, with a dissertation specifically examining the educational model used on the TV series, "Sesame Street": A Space Age Approach to Education for Space Age Kids.[4] She also recorded her now-classic Susan Sings Songs from Sesame Street album, as well as a rare RCA single under her own name. As the seasons progressed, Long's portrayal of Susan changed, affected by the scripts and complaints from NOW, so she was no longer merely a dispenser of milk and cookies, but playing a working woman as well as a wife.
Outside of Sesame Street, Long has taught courses and served as a guest lecturer on such issues as women in the media and the relationship between children and television:
"I think TV is like fire. It's good when it keeps you warm and bad if it burns your house down. TV is very popular and you need to be aware of what your children are watching. Don't turn it on because you are busy. I would like to see much less violence on TV cartoons; that really affects kids. But on the other hand, it can be a wonderful learning tool, as with Sesame Street.[2]"
As a performer, Long has appeared in summer stock versions of Guys and Dolls and Sweet Charity and sung in The Vaudeville '80 tour. In film, she appeared in both Sesame Street movies, Follow That Bird and The Adventures of Elmo in Grouchland, and had uncredited parts in Cotton Comes to Harlem, Husbands, and The Out of Towners. TV appearances, often accompanied by Big Bird, include The Dick Cavett Show, The Flip Wilson Show, You Bet Your Life, and The Today Show.
- ↑ Emmy TV Legends interview at 1:30 in part 1
- ↑ 2.0 2.1 Karkabi, Barbara. "TV Educator Dr. Long has RX for Youths." The Houston Chronicle. December 11, 1994.
- ↑ The Tavis Smiley Show. November 09, 2004.
- ↑ Hendershot, Heather. Saturday Morning Censors. p. 152